Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents

Journal of Nutrition

Volumn 130, Issue 2 SUPPL., 2000, Pages

  Kelloff, Gary J ^a   Crowell, James A ^a   Steele, Vernon E ^a   Lubet, Ronald A ^a   Malone, Winfred A ^a   Boone, Charles W ^a   Kopelovich, Levy ^a   Hawk, Ernest T ^a   Lieberman, Ronald ^a   Lawrence, Julia A ^a   Ali, Iqbal ^a   Viner, Jaye L ^a   Sigman, Caroline C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CCS Associates   (United States)

Author keywords

Breast; Cancer chemoprevention; Colon; Drug development; Food derived agents; Lung; Prostate

Indexed keywords

3 INDOLEMETHANOL; ALPHA TOCOPHEROL; CALCIUM; CURCUMIN; ISOFLAVONE DERIVATIVE; LYCOPENE; PERILLYL ALCOHOL; PHENETHYL ISOTHIOCYANATE; POLYPHENOL DERIVATIVE; SELENIUM; SULFUR DERIVATIVE; VITAMIN D;

BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CANCER; CONFERENCE PAPER; LUNG CANCER; PROSTATE CANCER;

CAMELLIA SINENSIS;

EID: 0033980370     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/130.2.467s     Document Type: Conference Paper

References (34)

1. Bagheri, D., Doeltz, M. K., Fay, J. R., Helmes, C. T., Monasmith, L. A. & Sigman, C. C. (1989) Database of inhibitors of carcinogenesis. J. Environ. Sci. Health 6: 261-414.
2. Baron, J. A., Beach, M., Mande, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., Bond, J. H. & Greenberg, E. R. (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium polyp prevention study group. N. Engl. J. Med. 340: 101-107.
3. Clark, L. C., Dalkin, B., Krongrad, A., Combs, G. F., Jr., Tumbull, B. W., Slate, E. H., Witherington, R., Herlong, J. H., Janosko, E., Carpenter, D., Borosso, C., Falk, S. & Rounder J. (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urol. 81: 730-734.
4. Fahey, J. W., Zhang, Y.-S. & Talalay, P. (1997) Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A. 94: 10367-10372.
5. Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmark, N. & other NSABP investigators (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 90: 1371-1388.
6. Gann, P. H., Ma, J., Giovannucci, E., Willett, W., Sacks, F. M., Hennekens, C. H. & Stampfer, M. J. (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 59: 1225-1230.
7. Gann, P. H., Manson, J. E., Glynn, R. J., Buring, J. E. & Hennekens, C. H. (1993) Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J. Natl. Cancer Inst. 85: 1220-1224.
8. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A. & Willett, W. C. (1995a) Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 87: 1767-1776.
9. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C. & Speizer, F. E. (1995b) Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333: 609-614.
10. Hamilton, S. R. (1992) The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J. Cell. Biochem. 16 (suppl. G): 41-46.
11. Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., Hartman, A. M., Haapakoski, J., Malila, N., Rautalahti, M., Ripatti, S., Maenpaa, H., Teerenhovi, L., Koss, L., Virolainen, M. & Edwards, B. K. (1998) Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J. Natl. Cancer Inst. 90: 440-446.
12. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. (1991) p53 Mutations in human cancers. Science (Washington, DC) 253: 49-53.
13. Kawamori, T., Rao, C. V., Seibert, K. & Reddy, B. S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58: 409-412.
14. Kelloff, G. J., Boone, C. W., Crowell, J. A., Nayfield, S. G., Hawk, E., Malone, W. F., Steele, V. E., Lubet, R. A. & Sigman, C. C. (1996a) Risk biomarkers and current strategies for cancer chemoprevention. J. Cell. Biochem. (suppl.) 25: 1-14.
15. Kelloff, G. J., Boone, C.W., Crowell, J. A., Steele, V. E., Lubet, R. & Doody, L. A. (1994a) Surrogate endpoint biomarkers for Phase II cancer chemoprevention trials. J. Cell. Biochem. (suppl. 19): 1-9.
16. Kelloff, G. J., Boone, C. W., Steele, V. E., Crowell, J. A., Lubet, R. A., Greenwald, P., Hawk, E. T., Fay, J. R. & Sigman, C. C. (1996b) Mechanistic considerations in the evaluation of chemopreventive data. Principles of Chemoprevention, IARC Scientific Publication No. 139, pp. 203-221, International Agency for Research on Cancer, Lyon, France.
17. Kelloff, G. J., Boone, C. W., Steele, V. E., Crowell, J. A., Lubet, R. & Sigman, C. C. (1994b) Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res. 54: 2015S-2024S.
18. Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R., Lubet, R. A., Crowell, J. A. & Sigman, C. C. (1994c) Mechanistic considerations in chemopreventive drug development. J. Cell. Biochem. (suppl. 20): 1-24.
19. Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R. & Sigman, C. C. (1995a) Inhibition of chemical carcinogenesis. In: Chemical Induction of Cancer: Modulation and Combination Effects (Arcos, J., Argus, M. & Woo, Y., eds.), pp. 73-122, Birkhaüser, Boston, MA.
20. Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., Hong, W. K., Parkinson, D. R., Bagheri, D., Baxter, G. T., Blunden, M., Doeltz, M. K., Eisenhauer, K. M., Johnson, K., Longfellow, D.G., Knapp, G. G., Malone, W. F., Nayfield, S. G., Seifried, H. E., Swall, L. M. & Sigman, C. C. (1996c) Clinical development plan: tea extracts, green tea polyphenols, epigallocatechin gallate. J. Cell. Biochem. (suppl. 26): 236-257.
21. Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., Hong, W. K., Parkinson, D. R., Bagheri, D., Baxter, G. T., Blunden, M., Doeltz, M. K., Eisenhauer, K. M., Johnson, K., Longfellow, D. G., Knapp, G. G., Malone, W. F., Nayfield, S. G., Seifried, H. E., Swall, L. M. & Sigman, C. C. (1996d) Clinical development plan: genistein. J. Cell. Biochem. (suppl. 26): 114-126.
22. Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., Hong, W. K., Parkinson, D. R., Bagheri, D., Baxter, G. T., Blunden, M., Doeltz, M. K., Eisenhauer, K. M., Johnson, K., Longfellow, D. G., Knapp, G. G., Malone, W. F., Nayfield, S. G., Seifried, H. E., Swall, L. M. & Sigman, C. C. (1996e) Clinical development plan: curcumin. J. Cell. Biochem. (suppl. 26): 72-85.
23. Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., Hong, W. K., Parkinson, D. R., Bagheri, D., Baxter, G. T., Blunden, M., Doeltz, M. K., Eisenhauer, K. M., Johnson, K., Longfellow, D. G., Knapp, G. G., Malone, W. F., Nayfield, S. G., Seifried, H. E., Swall, L. M. & Sigman, C. C. (1996f) Clinical development plan: phenethyl isothiocyanate (PEITC). J. Cell. Biochem. (suppl. 26): 149-157.
24. Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., Hong, W. K., Parkinson, D. R., Bagheri, D., Baxter, G. T., Blunden, M., Doeltz, M. K., Eisenhauer, K. M., Johnson, K., Longfellow, D. G., Knapp, G. G., Malone, W. F., Nayfield, S. G., Seifried, H. E., Swall, L. M. & Sigman, C. C. (1996g) Clinical development plan: indole-3-carbinol. J. Cell. Biochem. (suppl. 26): 127-136.
25. Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., Hong, W. K., Parkinson, D. R., Bagheri, D., Baxter, G. T., Blunden, M., Doeltz, M. K., Eisenhauer, K. M., Johnson, K., Longfellow, D. G., Knapp, G. G., Malone, W. F., Nayfield, S. G., Seifried, H. E., Swall, L. M. & Sigman, C. C. (1996h) Clinical development plan: perillyl alcohol. J. Cell. Biochem. (suppl. 26): 137-148.
26. Kelloff, G. J., Hawk, E. T., Crowell, J. A., Boone, C. W., Nayfield, S. G., Perloff, M., Steele, V. E., Lubet, R. A & Sigman, C. C. (1996i) Strategies for identification and clinical evaluation of promising chemopreventive agents. Oncology 10: 1471-1484.
27. Kelloff, G. J., Hawk, E. T., Karp, J. E., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A. & Sigman, C. C. (1997) Progress in clinical chemoprevention. Semin. Oncol. 24: 241-252.
28. Kelloff, G. J., Johnson, J. J., Crowell, J. A., Boone, C. W., DeGeorge, J. J., Steele, V. E., Mehta, M. U., Temeck, J. W., Schmidt, W. J., Burke, G., Greenwald, P. & Temple, R. J. (1995b) Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol. Biomark. Prev. 4: 1-10.
29. Kelloff, G. J., Lieberman, R. L., Steele, V. E., Boone, C. W., Lubet, R. A., Kopelovich, L., Malone, M. A., Crowell, J. A. & Sigman, C. C. (1999) Chemoprevention of prostate cancer: concepts and strategies. Eur. J. Urol. 35: 342-350.
30. Puisieux, A., Lim, S., Groopman, J. & Ozturk, M. (1991) Selective targeting of p53 gene mutational hotspots in human cancer by etiologically defined carcinogens. Cancer Res. 51: 6185-6189.
31. Steele, V. E., Moon, R. C., Lubet, R. A., Grubbs, C. J., Reddy, B. S., Wargovich, M., McCormick, D. L., Pereira, M. A., Crowell, J. A., Bagheri, D., Sigman, C. C., Boone, C. W. & Kelloff, G. J. (1994) Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemoprevention testing program. J. Cell. Biochem. (suppl. 20): 32-54.
32. Steele, V. E., Sharma, S., Mehta, R., Elmore, E., Redpath, L., Rudd, C., Carter, C., Bagheri, D., Sigman, C. C. & Kelloff, G. J. (1996) Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J. Cell. Biochem. (suppl. 26): 29-53.
33. Thun, M. J., Namboodiri, M. M. & Heath, C. W., Jr. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325: 1593-1596.
34. Winawer, S. J., O'Brien, M. J., Waye, J. D., Kronborg, O., Bond, J., Fruhmorgen, P., Sobin, L H., Burt, R., Zauber, A. & Morson, B. (1990) Risk and surveillance of individuals with colorectal polyps. Bull. WHO 68: 789-795.